Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-26-031445
Filing Date
2026-08-05
Accepted
2026-08-05 17:16:08
Documents
77
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20075111_10q.htm   iXBRL 10-Q 1693881
7 EX-10.1 ef20075111_ex10-1.htm EX-10.1 17220
8 EX-31.1 ef20075111_ex31-1.htm EX-31.1 10356
9 EX-31.2 ef20075111_ex31-2.htm EX-31.2 10803
10 EX-32.1 ef20075111_ex32-1.htm EX-32.1 4339
11 EX-32.2 ef20075111_ex32-2.htm EX-32.2 4359
  Complete submission text file 0001140361-26-031445.txt   8217618

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA adma-20260630.xsd EX-101.SCH 50830
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE adma-20260630_def.xml EX-101.DEF 268542
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE adma-20260630_lab.xml EX-101.LAB 536992
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE adma-20260630_pre.xml EX-101.PRE 309023
6 INLINE XBRL TAXONOMY EXTENSION - CALCULATION LINKBASE DOCUMENT adma-20260630_cal.xml EX-101.CAL 50236
81 EXTRACTED XBRL INSTANCE DOCUMENT ef20075111_10q_htm.xml XML 1414674
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36728 | Film No.: 261244839
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)